|
Estimated global and regional number of total cancer deaths (thousands) and mortality rate (per 100,000) by age, females, 2000 |
|||||||||
| Region |
Age-group |
||||||||
|
|
|||||||||
| 0–4 |
5–14 |
15–29 |
30–44 |
45–59 |
60–69 |
70–79 |
80+ |
Total |
|
|
|
|||||||||
| Number of deaths (000s) |
|||||||||
| World |
23.4 |
22.0 |
61.4 |
233.8 |
658.2 |
730.6 |
826.4 |
576.2 |
3,132.0 |
| AfrD |
2.9 |
1.2 |
4.4 |
12.0 |
30.0 |
35.8 |
31.7 |
14.4 |
132.3 |
| AfrE |
2.3 |
1.0 |
5.6 |
12.8 |
31.7 |
40.2 |
35.9 |
14.4 |
144.0 |
| AmrA |
0.3 |
0.5 |
1.6 |
12.6 |
48.4 |
57.8 |
88.7 |
91.1 |
301.1 |
| AmrB |
1.5 |
2.0 |
4.7 |
19.3 |
45.0 |
42.6 |
45.9 |
32.7 |
193.8 |
| AmrD |
0.6 |
0.6 |
1.4 |
4.2 |
9.4 |
8.5 |
9.3 |
5.6 |
39.6 |
| EmrB |
0.4 |
0.8 |
1.8 |
5.0 |
9.2 |
6.6 |
6.2 |
2.9 |
32.9 |
| EmrD |
0.7 |
1.0 |
1.9 |
5.5 |
8.8 |
6.4 |
5.6 |
1.6 |
31.4 |
| EurA |
0.3 |
0.6 |
2.1 |
16.2 |
64.0 |
87.1 |
145.1 |
152.0 |
467.4 |
| EurB1 |
0.3 |
0.4 |
1.8 |
7.9 |
22.1 |
27.1 |
29.9 |
14.4 |
104.0 |
| EurB2 |
0.1 |
0.2 |
0.6 |
2.3 |
3.6 |
4.3 |
3.6 |
1.1 |
15.9 |
| EurC |
0.4 |
0.7 |
2.5 |
14.6 |
44.1 |
60.9 |
72.6 |
28.7 |
224.5 |
| SearB |
1.5 |
2.0 |
3.7 |
19.1 |
44.6 |
31.4 |
23.4 |
13.1 |
138.8 |
| SearD |
6.9 |
5.9 |
17.2 |
34.2 |
100.6 |
113.8 |
85.8 |
60.5 |
425.0 |
| WprA |
0.1 |
0.1 |
0.7 |
4.3 |
20.4 |
24.9 |
37.2 |
45.5 |
133.1 |
| WprB1 |
4.8 |
4.3 |
9.8 |
58.5 |
165.9 |
175.7 |
198.8 |
91.8 |
709.7 |
| WprB2 |
0.4 |
0.4 |
1.4 |
5.0 |
9.9 |
7.2 |
6.4 |
6.2 |
36.9 |
| WprB3 |
0.0 |
0.0 |
0.1 |
0.4 |
0.6 |
0.3 |
0.2 |
0.1 |
1.7 |
|
|
|||||||||
| Age-specific mortality rate per 100,000 |
|||||||||
| World |
8.0 |
3.8 |
8.0 |
37.3 |
163.9 |
414.3 |
737.9 |
1,462.6 |
104.6 |
| AfrD |
10.6 |
2.6 |
9.6 |
44.6 |
206.1 |
641.3 |
1,204.5 |
2,286.7 |
78.9 |
| AfrE |
8.1 |
2.2 |
12.0 |
48.9 |
230.4 |
777.2 |
1,418.8 |
2,202.6 |
84.8 |
| AmrA |
2.7 |
2.4 |
5.3 |
34.7 |
166.6 |
484.1 |
862.1 |
1,663.3 |
193.4 |
| AmrB |
6.6 |
4.4 |
7.7 |
40.9 |
161.3 |
392.0 |
705.7 |
1,504.1 |
86.9 |
| AmrD |
12.5 |
7.5 |
13.2 |
65.1 |
260.9 |
602.3 |
1,226.6 |
2,479.1 |
110.8 |
| EmrB |
5.5 |
4.8 |
9.2 |
42.1 |
151.7 |
280.7 |
474.5 |
909.5 |
49.0 |
| EmrD |
7.4 |
5.9 |
10.1 |
43.8 |
124.7 |
237.8 |
411.1 |
481.1 |
46.1 |
| EurA |
2.9 |
2.6 |
5.4 |
34.6 |
162.9 |
397.0 |
781.7 |
1,751.8 |
224.7 |
| EurB1 |
5.0 |
3.4 |
8.3 |
45.3 |
166.0 |
394.8 |
632.1 |
1,134.8 |
124.4 |
| EurB2 |
2.5 |
4.1 |
9.1 |
44.1 |
150.2 |
326.0 |
463.3 |
491.3 |
61.9 |
| EurC |
6.4 |
4.5 |
9.1 |
52.2 |
192.2 |
417.0 |
661.6 |
851.5 |
172.7 |
| SearB |
7.3 |
5.1 |
6.6 |
45.4 |
187.2 |
329.0 |
491.8 |
991.1 |
70.5 |
| SearD |
8.8 |
4.0 |
9.7 |
27.2 |
136.1 |
383.2 |
580.4 |
1,570.4 |
65.1 |
| WprA |
2.0 |
1.7 |
4.7 |
29.0 |
125.6 |
290.5 |
580.5 |
1,509.3 |
176.2 |
| WprB1 |
9.9 |
3.9 |
6.0 |
35.7 |
165.9 |
435.6 |
839.7 |
1,262.3 |
107.6 |
| WprB2 |
6.0 |
2.9 |
6.8 |
32.1 |
132.6 |
215.4 |
342.3 |
1,113.7 |
51.5 |
| WprB3 |
3.5 |
3.0 |
9.5 |
68.4 |
184.5 |
233.3 |
294.1 |
960.7 |
51.7 |
Shibuya et al. BMC Cancer 2002 2:37 doi:10.1186/1471-2407-2-37 |
|||||||||